Trending
October 9, 2024 Catalio Capital Management Join $78 Million Financing For Orasis PharmaceuticalsAugust 28, 2024 NRx Pharma Subsidiary HOPE Therapeutics Secures $30M to Buy Ketamine ClinicsAugust 27, 2024 PreciseDx Uses AI to Predict Recurrence of Breast CancerAugust 22, 2024 Arsenal Capital Partners to Acquire Knowtion HealthAugust 22, 2024 Rafael Holdings and Cyclo Therapeutics To Merge
Featured
October 9, 2024
Catalio Capital Management Join $78 Million Financing For Orasis Pharmaceuticals
Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on reshaping vision possibilities, today... Read more »
August 28, 2024
NRx Pharma Subsidiary HOPE Therapeutics Secures $30M to Buy Ketamine Clinics
HOPE Therapeutics, a subsidiary of Wilmington, Del.-headquartered NRx Pharmaceuticals (Nasdaq: NRXP), has secured a $30... Read more »
August 27, 2024
PreciseDx Uses AI to Predict Recurrence of Breast Cancer
New York-based PreciseDx, which recently closed a $20.7 million Series B, is poised to advance AI-based technology that... Read more »
October 14, 2024
Orasis Pharmaceuticals Appoints Jeff Francis As VP Of Sales And Sam Fakhoury As VP Of Quality And Operations
October 9, 2024
Family Medicine Physician Teresa Colón-Asumu, M.D., MPH Joins Holy Cross Medical Group
October 3, 2024
HOPE Therapeutics and NRx Pharmaceuticals to Acquire a Premier West Coast Interventional Psychiatric Clinic
September 12, 2024
Celebration Pediatrics Appoints Dr. Victoria Larson, MD, To Their Team Of Expert Pediatricians
